Skip to main content

Survey: Few Women With Uterine Fibroids Offered Less Invasive Treatment Options

Medically reviewed by Carmen Pope, BPharm. Last updated on July 25, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, July 24, 2024 -- Most U.S. women with uterine fibroids report being offered hysterectomies over minimally invasive treatments, according to survey results released by the Society of Interventional Radiology.

The online survey, conducted by the Harris Poll from May 30 to June 3, 2024, included 1,122 U.S. women (≥18 years), including 167 who reported being personally diagnosed with uterine fibroids.

Results showed that more than half of respondents with fibroids (53 percent) were presented with a hysterectomy, while fewer than one in five were presented with less invasive options such as over-the-counter nonsteroidal anti-inflammatory drugs (19 percent), uterine fibroid embolization (17 percent), oral contraceptives (17 percent), and endometrial ablation (17 percent). More than one in six women (17 percent) mistakenly believed a hysterectomy is the only treatment option, which was even more common in younger women (aged 18 to 34 years: 27 percent).

"The survey noted deep disparities in awareness and access regarding fibroids and fibroid treatments among Black and Hispanic women, who have a higher risk factor for developing uterine fibroids," Robert J. Lewandowski, M.D., president of the Society of Interventional Radiology, said in a statement. "The data serve as a guiding light for improving physician and patient educational efforts on various treatments to ensure all women, regardless of background, are informed about their risks and the full range of treatment options available."

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Gender-Based Variation Seen in Medicare Reimbursement for Surgery

THURSDAY, July 25, 2024 -- Considerable gender-based variation is seen in practice patterns and reimbursement among different surgical subspecialties serving the Medicare...

Preop Lab Values May ID Risk of Postarthroplasty Joint Infection in Morbid Obesity

THURSDAY, July 25, 2024 -- Certain preoperative laboratory values may predict risk of periprosthetic joint infection (PJI) among individuals with morbid obesity undergoing...

Nudge in EHR Can Reduce Unnecessary Sentinel Lymph Node Biopsy

THURSDAY, July 25, 2024 -- A nudge intervention in the electronic health record (EHR) targeting surgeons can reduce sentinel lymph node biopsy (SLNB) among women who meet the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.